The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials

被引:0
|
作者
Xuexue Zhang
Yuting Tang
Miaoran Wang
Dongsheng Wang
Qiuyan Li
机构
[1] China Academy of Chinese Medical Sciences,Department of endocrinology
[2] Central South University,Department of Integrative Chinese and Western Medicine
[3] Beijing University of Chinese Medicine,Department of endocrinology
[4] Central South University,Institute of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital
[5] China Academy of Chinese Medical Sciences,Department of general medicine, Xiyuan Hospital
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Acute gout; Clinical efficacy; Meta-analysis; Urate-lowering therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:701 / 710
页数:9
相关论文
共 50 条
  • [21] Treatment approaches and adherence to urate-lowering therapy for patients with gout
    Aung, Thanda
    Myung, Gihyun
    FitzGerald, John D.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 795 - 800
  • [22] Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review
    Sinnappah, Klarissa A.
    Stocker, Sophie L.
    Chan, Jian Sheng
    Hughes, Dyfrig A.
    Wright, Daniel F. B.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (03) : 215 - 225
  • [23] Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis
    te Kampe, Ritch
    Nielsen, Sabrina Mai
    Hotea, Ioana
    van Durme, Caroline
    Christensen, Robin
    Boonen, Annelies
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 56
  • [24] Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Coleshill, Matthew J.
    Aung, Eindra
    Carland, Jane E.
    Faasse, Kate
    Stocker, Sophie
    Day, Richard O.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 138 - 141
  • [25] Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Matthew J. Coleshill
    Eindra Aung
    Jane E. Carland
    Kate Faasse
    Sophie Stocker
    Richard O. Day
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 138 - 141
  • [26] Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Chang, Chia-Ling
    Yang, Chen-Chang
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (12): : 2599 - 2606
  • [27] Preventing Attacks of Acute Gout When Introducing Urate-Lowering Therapy: A Systematic Literature Review
    Seth, Rakhi
    Kydd, Alison S. R.
    Falzon, Louise
    Bombardier, Claire
    van der Heijde, Desiree M.
    Edwards, Christopher J.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 : 42 - 47
  • [28] Efficacy of Cellular Therapy for Diabetic Foot Ulcer: A Meta-Analysis of Randomized Controlled Clinical Trials
    Zhang, Ye
    Deng, Hong
    Tang, Zhouping
    CELL TRANSPLANTATION, 2017, 26 (12) : 1931 - 1939
  • [29] Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis
    Borghi, C.
    Perez-Ruiz, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (05) : 983 - 992
  • [30] Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
    Liu, Ching-Han
    Huang, Shih-Chung
    Yin, Chun-Hao
    Huang, Wei-Chun
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Gan, Su-Ting
    Tzou, Shiow-Jyu
    Hsu, Ching-Tsai
    Wu, Hao-Ming
    Wang, Wen-Hwa
    BIOMEDICINES, 2023, 11 (01)